News

A WOMAN who’s shed nearly 25% of her bodyweight thanks to Mounjaro has revealed which foods she steered clear of. TikToker ...
Three studies presented today at the Society of NeuroInterventional Surgery’s (SNIS) 22nd Annual Meeting discussed whether ...
The stock needs a compound annual growth rate of 12.2% to double in the next six years. Novo Nordisk can pull it off, ...
Polycystic Ovary Syndrome or PCOS affects millions of women in the United States. There is currently no standard treatment for it. Weight loss drugs like semaglutide are now showing positive results.
A new study has found that older adults and women taking the weight-loss drug semaglutide may lose more muscle than others, ...
GLP-1 receptor agonists semaglutide and tirzepatide are associated with reduced risks of dementia, stroke, and mortality in adults with type 2 diabetes and obesity, new data show.
Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...
A new study suggests that drugs like Ozempic and Mounjaro may reduce dementia risk. Researchers at the University of Galway ...
With their lengthening laundry list of health benefits, drugs like Ozempic are showing promise for people who struggle with addiction.
Pre-diabetes now affects as many as one-third of children ages 12-17. As a physician this is why Ozempic should still not be ...
People who took semaglutide over a slower, more flexible schedule were significantly less likely to experience nausea and to ...
Glucagon-like peptide 1 receptor agonists may offer neuroprotective and survival benefits beyond blood sugar control.